CXCL9, but not CXCL10, promotes CXCRS-dependent immune-mediated kidney disease

Journal of the American Society of Nephrology

Volumn 19, Issue 6, 2008, Pages 1177-1189

  Menke, Julia ^a   Zeller, Geraldine C ^a   Kikawada, Eriya ^a   Means, Terry K ^b   Huang, Xiao R ^d   Lan, Han Y ^d   Lu, Bao ^c   Farber, Joshua ^e   Luster, Andrew D ^b   Kelley, Vicki Rubin ^a,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; FAS ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; MONOCYTE CHEMOTACTIC PROTEIN 1; CXCR3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLOMERULUS; HISTOPATHOLOGY; IMMUNE MEDIATED INJURY; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION; MACROPHAGE; MALE; MOUSE; NEPHRITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE; UPREGULATION; WILD TYPE; ANIMAL; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CHEMOKINE CXCL10; CHEMOKINE CXCL9; MICE; NEPHRITIS; RECEPTORS, CXCR3;

EID: 48049088172     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007111179     Document Type: Article

References (54)

1. Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18: 593-620, 2000
2. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242, 2000
3. Segerer S, Cui Y, Hudkins KL, Goodpaster T, Eitner F, Mack M, Schlondorff D, Alpers CE: Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 11: 2231-2242, 2000
4. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD: IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168: 3195-3204, 2002
5. Anders HJ, Vielhauer V, Schlondorff D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415, 2003
6. Vielhauer V, Anders HJ, Schlondorff D: Chemokines and chemokine receptors as therapeutic targets in lupus nephritis. Semin Nephrol 27: 81-97, 2007
7. Premack BA, Schall TJ: Chemokine receptors: Gateways to inflammation and infection. Nat Med 2: 1174-1178, 1996
8. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31: 964-972, 1987
9. Kelley VE, Roths JB: Interaction of mutant lpr gene with background strain influences renal disease. Clin Immunol Immunopatnol 37: 220-229, 1985
10. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR: Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 190: 1813-1824, 1999
11. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103: 73-80, 1999
12. Moore KJ, Wada T, Barbee SD, Kelley VR: Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(lpr) mice. Kidney Int 53: 1631-1641, 1998
13. Luster AD, Ravetch JV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 166: 1084-1097, 1987
14. Xie JH, Nomura N, Lu M, Chen SL, Koch GE, Weng Y, Rosa R, Di Salvo J, Mudgett J, Peterson LB, Wicker LS, DeMartino JA: Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J Leukoc Biol 73: 771-780, 2003
15. Liu L, Callahan MK, Huang D, Ransohoff RM: Chemokine receptor CXCR3: An unexpected enigma. Curr Top Dev Biol 68: 149-181, 2005
16. Fiorina P, Ansari MJ, Jurewicz M, Barry M, Ricchiuti V, Smith RN, Shea S, Means TK, Auchincloss H Jr, Luster AD, Sayegh MH, Abdi R: Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 17: 716-723, 2006
17. Shiozawa F, Kasama T, Yajima N, Odai T, Isozaki T, Matsunawa M, Yoda Y, Negishi M, Ide H, Adachi M: Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice. Arthritis Res Ther 6: R78-R86, 2004
18. Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, Kovac AD, Gerard C, Boddeke HW, Nitsch R, Kettenmann H: CXCRS-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 24: 8500-8509, 2004
19. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101: 746-754, 1998
20. Dean EG, Wilson GR, Li M, Edgtton KL, O'Sullivan KM, Hudson BG, Holdsworth SR, Kitching AR: Experimental autoimmune Goodpasture's disease: A pathogenetic role for both effector cells and antibody in injury. Kidney Int 67: 566-575, 2005
21. Izui S, Fossati-Jimack L, da Silveira SA, Moll T: Isotype-dependent pathogenicity of autoantibodies: Analysis in experimental autoimmune hemolytic anemia. Springer Semin Immunopathol 23: 433-445, 2001
22. Perez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlondorff D: Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12: 1369-1382, 2001
23. Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MB: Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171: 6838-6845, 2003
24. Salomon I, Netzer N, Wildbaum G, Schif-Zuck S, Maor G, Karin N: Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J Immunol 169: 2685-2693, 2002
25. Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD: IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J Immunol 172: 550-559, 2004
26. Han GD, Suzuki K, Koike H, Yoneyama H, Narumi S, Shimizu F, Kawachi H: IFN-inducible protein-10 plays a pivotal role in maintaining slit-diaphragm function by regulating podocyte cell-cycle balance. J Am Soc Nephrol 17: 442-453, 2006
27. Panzer U, Steinmetz OM, Reinking RR, Meyer TN, Fehr S, Schneider A, Zahner G, Wolf G, Helmchen U, Schaerli P, Stahl RA, Thaiss F: Compartment-specific expression and function of the chemokine IP-10/ CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 17: 454-464, 2006
28. Panzer U, Steinmetz OM, Paust HJ, Meyer-Schwesinger C, Peters A, Turner JE, Zahner G, Heymann F, Kurts C, Hopfer H, Helmchen U, Haag F, Schneider A, Stahl RA: Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol 18: 2071-2084, 2007
29. Liu MT, Keirstead HS, Lane TE: Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 167: 4091-4097, 2001
30. Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F: Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J Immunol 177: 1855-1863, 2006
31. Wuest T, Farber J, Luster A, Carr DJ: CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell Immunol 243: 83-89, 2006
32. Salazar-Mather TP, Hamilton TA, Biron CA: A chemokine-to-cytokine-to- chemokine cascade critical in antiviral defense. J Clin Invest 105: 985-993, 2000
33. Katschke KJ Jr, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE: Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 44: 1022-1032, 2001
34. Park MK, Amichay D, Love P, Wick E, Liao F, Grinberg A, Rabin RL, Zhang HH, Gebeyehu S, Wright TM, Iwasaki A, Weng Y, DeMartino JA, Elkins KL, Farber JM: The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J Immunol 169: 1433-1443, 2002
35. Rabin RL, Alston MA, Sircus JC, Knollmann-Ritschel B, Moratz C, Ngo D, Farber JM: CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions. J Immunol 171: 2812-2824, 2003
36. Muehlinghaus G, Cigliano L, Huehn S, Peddinghaus A, Leyendeckers H, Hauser AE, Hiepe F, Radbruch A, Arce S, Manz RA: Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 105: 3965-3971, 2005
37. Rosenkranz AR, Knight S, Sethi S, Alexander Sl, Cotran RS, Mayadas TN: Regulatory interactions of alphabeta and gammadelta T cells in glomerulonephritis. Kidney Int 58: 1055-1066, 2000
38. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD: Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 193: 975-980, 2001
39. Wu J, Zhou T, He J, Mountz JD: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178: 461-468, 1993
40. Kikawada E, Lenda DM, Kelley VR: IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol 170: 3915-3925, 2003
41. Tipping PG, Cornthwaite LJ, Holdsworth SR: Beta 2 integrin independent neutrophil recruitment and injury in anti-GBM glomerulonephritis in rabbits, Immunol Cell Biol 72: 471-479, 1994
42. Vielhauer V, Stavrakis G, Mayadas TN: Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 115: 1199-1209, 2005
43. Abdi R, Means TK, Ito T, Smith RN, Najafian N, Jurewicz M, Tchipachvili V, Charo I, Auchincloss H Jr, Sayegh MH, Luster AD: Differential role of CCR2 in islet and heart allograft rejection: Tissue specificity of chemokine/chemokine receptor function in vivo. J Immunol 172: 767-775, 2004
44. Means TK, Hayashi F, Smith KD, Aderem A, Luster AD: The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 170: 5165-5175, 2003
45. Lenda DM, Stanley ER, Kelley VR: Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. J Immunol 173: 4744-4754, 2004
46. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE: MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37: 783-792, 1990
47. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in streptozotocin-induced diabetic nephropathy: Potential role in renal fibrosis. Nephrol Dial Transplant 19: 2987-2996, 2004
48. Lenda D, Kikawada E, Stanley ES, Kelley VR: Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170: 3254-3262, 2003
49. Faraggiana T, Malchiodi F, Prado A, Churg J: Lectin-peroxidase conjugate reactivity in normal human kidney. J Histochem Cytochem 30: 451-458, 1982
50. Swinford AE, Bernstein J, Toriello HV, Higgins JV: Renal tubular dysgenesis: Delayed onset of oligohydramnios. Am J Med Genet 32: 127-132, 1989
51. Moore KJ, Naito T, Martin C, Kelley VR: Enhanced response of macrophages to CSF-1 in autoimmune mice: A gene transfer strategy. J Immunol 157: 433-440, 1996
52. Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR: IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL- Fas(lpr) mice. J Immunol 161: 494-503, 1998
53. Topham PS, Csizmadia V, Soler D, Hines D, Gerard CJ, Salant DJ, Hancock WW: Lack of chemokine receptor CCRI enhances Th 1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 104: 1549-1557, 1999
54. Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR: Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol 164: 6046-6056, 2000